The State Of The Prostacycline-Thromboxane System In Patients With Ischemic Heart Disease
Khattahanova Rabiya Yuldashevna, , Candidate Of Medical Sciences, Senior Lecturer Of The Department Of Internal Diseases No.1, Fergana Branch Of The Tashkent Medical Academy, Fergana City, The Republic Of UzbekistanAbstract
The aim of the work was to study the state of the prostacyclin-thromboxane system (PTS)
and platelet functions in patients with coronary heart disease (CHD). 86 patients with CHD
were examined. The state of PTS was examined by the content of prostacyclin and
thromboxane in the blood, determined by radioimmunological method. Platelet hemostasis
was studied by the aggregation properties of platelets and the platelet release reaction for
β-thromboglobulin determined by radio immunological method. In patients with IHD,
pronounced violations of the prostacyclin-thromboxane balance in the direction of the
predominance of thromboxane and an increase in the functional activity of platelets,
expressed in increased aggregation and platelet release reaction. In patients with IHD
with post infarction cardio sclerosis, the level of prostacyclin in the blood significantly
exceeds the level in patients without myocardial infarction. The content of prostacyclin and
thromboxane in the blood does not differ in patients with stable angina of functional
classes III and IY.
Keywords
prostacyclin-thromboxane system, platelet aggregation,
References
Adaptation, stress and prevention. 2001. pp. 215-226.
Alekseeva N. P., Makoeva L. D. Influence of exogenous prostaglandins on the
cardiovascular system. // Medicine. 2005. pp. 96-99.
Baluda V. P. the Role of PG, Tha2 and PGI2 in regulating the aggregation process and
platelet release reaction in normal and pathological conditions. // Pathological physiology
and experimental therapy. 2004. issue 4. pp. 80-85.
Baluda V. P. Platelet-vascular link of the hemostasis system in patients with ischemic
heart disease under conditions of emotional stress. // Dissertation ... candidate of medical
Sciences. 1994.
Biological active substances in General anesthesia and intensive care. // Himmelfarb G.
N., Gerasimov N. M. Tashkent, Medicine, 2000, p. 192.
Boroyan R. G. Cardiovascular effects of prostaglandins and data on the mechanisms of
their action. // Dissertation ... doctor of medical Sciences. 2004
Ismailov sh. I., Valdman A.V. the Role of prostacyclin and thromboxane in the
cardiovascular system. // Cardiology. 2001. No. 3, p. 111-116.
Сhelly J. E., Fricot A.M, Garoia A. Hemodinamics effects of prostaciclin infusion after
coronary bypass surgery. // Clinlcal pharmacology of prostaciclin. Edltors P. G. Lewis , J.
O.Grady, Raven press, 2006 , p. 209-214
Article Statistics
Copyright License
Copyright (c) 2020 The American Journal of Medical Sciences and Pharmaceutical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.